Leuprolide acetate 1-, 3- and 6-monthly depot formulations in androgen deprivation therapy for prostate cancer in nine European countries: evidence review and economic evaluation

Androgen Deprivation ◽

Leuprolide Acetate ◽

European Countries ◽

Evidence Review

PCN102 Economic Evaluation of Three Formulations of Leuprolide Acetate With Atrigel® in Androgen Deprivation Therapy for Advanced Prostate Cancer in Nine European Countries

Value in Health ◽

10.1016/j.jval.2011.08.1203 ◽

2011 ◽

Vol 14 (7) ◽

pp. A452-A453

Author(s):

P. Retsa ◽

M. Sidhu ◽

I. Odeyemi ◽

B. Tombal ◽

J. Wex

Keyword(s):

Prostate Cancer ◽

Economic Evaluation ◽

Androgen Deprivation ◽

Leuprolide Acetate ◽

European Countries

PCN64 ECONOMIC EVALUATION OF THREE FORMULATIONS OF LEUPROLIDE ACETATE IN ANDROGEN DEPRIVATION THERAPY FOR ADVANCED PROSTATE CANCER IN BELGIUM

Value in Health ◽

10.1016/j.jval.2011.02.919 ◽

2011 ◽

Vol 14 (3) ◽

pp. A166

Author(s):

J. Wex ◽

M. Sidhu ◽

I. Odeyemi ◽

P. Retsa

Keyword(s):

Prostate Cancer ◽

Economic Evaluation ◽

Androgen Deprivation ◽

Leuprolide Acetate

PCN65 ECONOMIC EVALUATION OF THREE FORMULATIONS OF LEUPROLIDE ACETATE IN ANDROGEN DEPRIVATION THERAPY FOR ADVANCED PROSTATE CANCER IN PORTUGAL

Value in Health ◽

10.1016/j.jval.2011.02.920 ◽

2011 ◽

Vol 14 (3) ◽

pp. A166

Author(s):

J. Wex ◽

M. Sidhu ◽

I. Odeyemi ◽

P. Retsa

Keyword(s):

Prostate Cancer ◽

Economic Evaluation ◽

Androgen Deprivation ◽

Leuprolide Acetate

Re: Intense Androgen-Deprivation Therapy with Abiraterone Acetate plus Leuprolide Acetate in Patients with Localized High-Risk Prostate Cancer: Results of a Randomized Phase II Neoadjuvant Study

10.1016/j.juro.2015.03.046 ◽

2015 ◽

Vol 193 (6) ◽

pp. 1983-1983

Author(s):

Samir S. Taneja

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Phase Ii ◽

Abiraterone Acetate ◽

Androgen Deprivation ◽

Leuprolide Acetate ◽

High Risk Prostate Cancer ◽

Randomized Phase Ii ◽

Risk Prostate Cancer

Economic Evaluation of Abiraterone in Metastatic Castration-Resistant Prostate Cancer in Patients With None/Mild Symptoms After Failure of Androgen Deprivation Therapy

Value in Health ◽

10.1016/j.jval.2017.08.270 ◽

2017 ◽

Vol 20 (9) ◽

pp. A446

Author(s):

A Abotaleb ◽

AS Saad

Keyword(s):

Prostate Cancer ◽

Economic Evaluation ◽

Androgen Deprivation ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Androgen deprivation therapy with Leuprolide acetate for treatment of advanced prostate cancer

Expert Opinion on Pharmacotherapy ◽

10.1080/14656566.2016.1258058 ◽

2016 ◽

Vol 18 (1) ◽

pp. 105-113 ◽

Cited By ~ 6

Author(s):

M. Raschid Hoda ◽

Mario W. Kramer ◽

Axel S. Merseburger ◽

Marcus V. Cronauer

Keyword(s):

Prostate Cancer ◽

Androgen Deprivation ◽

Leuprolide Acetate

598: Increased Risk of Newly Diagnosed Comorbidities in Prostate Cancer Patients Treated with Androgen Deprivation Therapy

10.1016/s0022-5347(18)30838-3 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 200-200 ◽

Cited By ~ 1

Author(s):

Andrea Gallina ◽

Pierre I. Karakiewicz ◽

Jochen Walz ◽

Claudio Jeldres ◽

Quoc-Dien Trinh ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Androgen Deprivation ◽

Newly Diagnosed ◽

Increased Risk

1015: Phase III Interim Analysis Demonstrates Toremifene Increases Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

10.1016/s0022-5347(18)31243-6 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 335-335 ◽

Cited By ~ 1

Author(s):

Matthew R. Smith ◽

F. Chu ◽

J. Forrest ◽

S. Bruce Malkowicz ◽

David Price ◽

...

Keyword(s):

Prostate Cancer ◽

Bone Mineral Density ◽

Bone Mineral ◽

Interim Analysis ◽

Androgen Deprivation ◽

Phase Iii ◽

Mineral Density

199: Health Care Cost Associated with Prostate Cancer, Androgen Deprivation Therapy, and Bone Complications

10.1016/s0022-5347(18)32466-2 ◽

2006 ◽

Vol 175 (4S) ◽

pp. 65-65

Author(s):

Tracey L. Krupski ◽

Kathleen A. Foley ◽

Onur Baser ◽

Stacey R. Long ◽

David Macarios ◽

...

Keyword(s):

Prostate Cancer ◽

Health Care ◽

Health Care Cost ◽

Androgen Deprivation ◽

Bone Complications

128: Androgen Deprivation Therapy and Risk of Diabetes Mellitus in Men Undergoing Androgen Deprivation Therapy for Prostate Cancer

10.1016/s0022-5347(18)32395-4 ◽

2006 ◽

Vol 175 (4S) ◽

pp. 41-41

Author(s):

Matt C. Kincade ◽

Ithaar H. Derweesh ◽

John Malcolm ◽

Kimberly D. Lamar ◽

Anthony L. Patterson ◽

...

Keyword(s):

Prostate Cancer ◽

Diabetes Mellitus ◽

Androgen Deprivation